摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-bromo-N-(3-bromo-4-methoxyphenethyl)-1H-pyrrole-2-carboxamide | 1069472-63-4

中文名称
——
中文别名
——
英文名称
4-bromo-N-(3-bromo-4-methoxyphenethyl)-1H-pyrrole-2-carboxamide
英文别名
4-bromo-N-[2-(3-bromo-4-methoxyphenyl)ethyl]-1H-pyrrole-2-carboxamide
4-bromo-N-(3-bromo-4-methoxyphenethyl)-1H-pyrrole-2-carboxamide化学式
CAS
1069472-63-4
化学式
C14H14Br2N2O2
mdl
——
分子量
402.085
InChiKey
WXVUYAGLUQVJJX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    54.1
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF<br/>[FR] ANALOGUES DE DYSPYRINE NON NATURELS, LEURS PRÉPARATIONS ET LEURS UTILISATIONS
    申请人:UNIV VANDERBILT
    公开号:WO2009152071A1
    公开(公告)日:2009-12-17
    Disclosed are dispyrin analogue compounds useful as H3 receptor activity modulators, methods of making same, pharmaceutical compositions comprising same, and methods of treating neurological and psychiatric disorders associated with histamine H3 receptor activity using same. In one aspect, the disclosed analogues can have a structure represented by a formula: (I), This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    本公开揭示了作为H3受体活性调节剂有用的dispyrin类似化合物,制备方法,包含同样化合物的药物组合物,以及使用同样化合物治疗与组胺H3受体活性相关的神经和精神障碍的方法。在一个方面,所公开的类似物可以具有以下式表示的结构:(I)。本摘要旨在作为在特定领域进行搜索的扫描工具,不打算限制本发明。
  • Total Synthesis and Biological Evaluation of the Marine Bromopyrrole Alkaloid Dispyrin: Elucidation of Discrete Molecular Targets with Therapeutic Potential
    作者:J. Phillip Kennedy、John T. Brogan、Craig W. Lindsley
    DOI:10.1021/np800339e
    日期:2008.10.24
    The first total synthesis of dispyrin, a recently reported bromopyrrole alkaloid from Agelas dispar with an unprecedented bromopyrrole tyramine motif, was achieved in three steps on a gram scale (69.4% overall). No biological activity was reported for dispyrin, so we evaluated synthetic dispyrin against > 200 discrete molecular targets in radioligand binding and functional assays. Unlike most marine natural products, dispyrin (1) possesses no antibacterial or anticancer activity, but was found to be it potent ligand and antagonist of several therapeutically relevant GPCRs, the alpha(1D) and alpha(2A) adrenergic receptors and the H2 and H3 histamine receptors.
  • UNNATURAL DISPYRIN ANALOGUES, PREPARATION AND USES THEREOF
    申请人:Lindsley Craig W.
    公开号:US20100035929A1
    公开(公告)日:2010-02-11
    Disclosed are dispyrin analogue compounds useful as H3 receptor activity modulators, methods of making same, pharmaceutical compositions comprising same, and methods of treating neurological and psychiatric disorders associated with histamine H3 receptor activity using same. In one aspect, the disclosed analogues can have a structure represented by a formula: This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
  • A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin
    作者:J. Phillip Kennedy、P. Jeffrey Conn、Craig W. Lindsley
    DOI:10.1016/j.bmcl.2009.04.106
    日期:2009.6
    Letter describes the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin, and the resulting SAR of H3 antagonism. Multiple rounds of iterative parallel synthesis improved human H3 IC50 ∼33-fold, and afforded a new class of H3 antagonists based on the novel bromotyramine core of dispyrin.
    这封信描述了天然产物引导合成的海洋溴吡咯生物碱 dispyrin 的非天然类似物,以及由此产生的 H 3拮抗作用的SAR 。多轮迭代平行合成将人类 H 3 IC提高了50 ∼33 倍,并提供了一类新的 H 3拮抗剂,该拮抗剂基于新的双吡啉溴酪胺核心。
查看更多